229 related articles for article (PubMed ID: 19818058)
1. Value of information analyses of economic randomized controlled trials: the treatment of intermittent claudication.
Groot Koerkamp B; Spronk S; Stijnen T; Hunink MG
Value Health; 2010; 13(2):242-50. PubMed ID: 19818058
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial.
Spronk S; Bosch JL; den Hoed PT; Veen HF; Pattynama PM; Hunink MG
J Vasc Surg; 2008 Dec; 48(6):1472-80. PubMed ID: 18771879
[TBL] [Abstract][Full Text] [Related]
3. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
Siebert U; Rochau U; Claxton K
Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
[TBL] [Abstract][Full Text] [Related]
4. Design of the multicenter standardized supervised exercise training intervention for the claudication: exercise vs endoluminal revascularization (CLEVER) study.
Bronas UG; Hirsch AT; Murphy T; Badenhop D; Collins TC; Ehrman JK; Ershow AG; Lewis B; Treat-Jacobson DJ; Walsh ME; Oldenburg N; Regensteiner JG;
Vasc Med; 2009 Nov; 14(4):313-21. PubMed ID: 19808716
[TBL] [Abstract][Full Text] [Related]
5. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy.
de Vries SO; Visser K; de Vries JA; Wong JB; Donaldson MC; Hunink MG
Radiology; 2002 Jan; 222(1):25-36. PubMed ID: 11756701
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial.
Reynolds MR; Apruzzese P; Galper BZ; Murphy TP; Hirsch AT; Cutlip DE; Mohler ER; Regensteiner JG; Cohen DJ
J Am Heart Assoc; 2014 Nov; 3(6):e001233. PubMed ID: 25389284
[TBL] [Abstract][Full Text] [Related]
7. Absence of Long-Term Benefit of Revascularization in Patients With Intermittent Claudication: Five-Year Results From the IRONIC Randomized Controlled Trial.
Djerf H; Millinger J; Falkenberg M; Jivegård L; Svensson M; Nordanstig J
Circ Cardiovasc Interv; 2020 Jan; 13(1):e008450. PubMed ID: 31937137
[TBL] [Abstract][Full Text] [Related]
8. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease.
Mazari FA; Khan JA; Carradice D; Samuel N; Gohil R; McCollum PT; Chetter IC
Br J Surg; 2013 Aug; 100(9):1172-9. PubMed ID: 23842831
[TBL] [Abstract][Full Text] [Related]
9. Value of information analysis optimizing future trial design from a pilot study on catheter securement devices.
Tuffaha HW; Reynolds H; Gordon LG; Rickard CM; Scuffham PA
Clin Trials; 2014 Dec; 11(6):648-56. PubMed ID: 25084784
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of supervised exercise therapy compared with endovascular revascularization for intermittent claudication.
van den Houten MM; Lauret GJ; Fakhry F; Fokkenrood HJ; van Asselt AD; Hunink MG; Teijink JA
Br J Surg; 2016 Nov; 103(12):1616-1625. PubMed ID: 27513296
[TBL] [Abstract][Full Text] [Related]
11. Would a Large tPA Trial for Those 4.5 to 6.0 Hours from Stroke Onset Be Good Value for Information?
Soeteman DI; Menzies NA; Pandya A
Value Health; 2017; 20(7):894-901. PubMed ID: 28712618
[TBL] [Abstract][Full Text] [Related]
12. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods.
Murphy TP; Hirsch AT; Ricotta JJ; Cutlip DE; Mohler E; Regensteiner JG; Comerota AJ; Cohen DJ;
J Vasc Surg; 2008 Jun; 47(6):1356-63. PubMed ID: 18440181
[TBL] [Abstract][Full Text] [Related]
13. Significant savings with a stepped care model for treatment of patients with intermittent claudication.
Fokkenrood HJ; Scheltinga MR; Koelemay MJ; Breek JC; Hasaart F; Vahl AC; Teijink JA
Eur J Vasc Endovasc Surg; 2014 Oct; 48(4):423-9. PubMed ID: 24951374
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of exercise therapy in patients with intermittent claudication: supervised exercise therapy versus a 'go home and walk' advice.
van Asselt AD; Nicolaï SP; Joore MA; Prins MH; Teijink JA;
Eur J Vasc Endovasc Surg; 2011 Jan; 41(1):97-103. PubMed ID: 21159527
[TBL] [Abstract][Full Text] [Related]
15. Endovascular intervention for treatment of claudication: is it cost-effective?
O'Brien-Irr MS; Harris LM; Dosluoglu HH; Dryjski ML
Ann Vasc Surg; 2010 Aug; 24(6):833-40. PubMed ID: 20638623
[TBL] [Abstract][Full Text] [Related]
16. How much is another randomized trial of lymph node dissection in endometrial cancer worth? A value of information analysis.
Havrilesky LJ; Chino JP; Myers ER
Gynecol Oncol; 2013 Oct; 131(1):140-6. PubMed ID: 23800699
[TBL] [Abstract][Full Text] [Related]
17. Using value of information methods to determine the optimal sample size for effectiveness trials of alcohol interventions for HIV-infected patients in East Africa.
Li L; Uyei J; Nucifora KA; Kessler J; Stevens ER; Bryant K; Braithwaite RS
BMC Health Serv Res; 2018 Jul; 18(1):590. PubMed ID: 30064428
[TBL] [Abstract][Full Text] [Related]
18. The value of value of information: best informing research design and prioritization using current methods.
Eckermann S; Karnon J; Willan AR
Pharmacoeconomics; 2010; 28(9):699-709. PubMed ID: 20629473
[TBL] [Abstract][Full Text] [Related]
19. Two-level resampling as a novel method for the calculation of the expected value of sample information in economic trials.
Sadatsafavi M; Marra C; Bryan S
Health Econ; 2013 Jul; 22(7):877-82. PubMed ID: 22933363
[TBL] [Abstract][Full Text] [Related]
20. Decision Criterion and Value of Information Analysis: Optimal Aspirin Dosage for Secondary Prevention of Cardiovascular Events.
Basu A; Meltzer D
Med Decis Making; 2018 May; 38(4):427-438. PubMed ID: 29529923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
